Hoshi K, Fujino S
Jpn J Pharmacol. 1980 Aug;30(4):427-35. doi: 10.1254/jjp.30.427.
To further clarify the hypotensive mechanism of adrenergic alpha blockers, effects of several alpha blockers on systemic blood pressure and on Ca-contracture of isolated, cat aortic strips were studied. For this purpose, the effects of known adrenergic alpha blockers, phentolamine, phenoxybenzamine, and a newly synthesized adrenergic alpha blocker (2-(N-(n-Butyloyl)homopiperazine-N'-yl)-4-amino-6,7-dimethoxy quinazoline; E-643) were compared with those of nitroglycerin and verapamil. Systemic blood pressure was decreased by administration (2 x 10(-8) moles/kg i.v.) of all drugs except phenoxybenzamine. The order of maximal fall of diastolic blood pressure after the injection was; nitroglycerin greater than E-643 greater than phentolamine greater than verapamil greater than phenoxybenzamine. Although "adrenaline reversal" was observed after 2 x 10(-7) moles/kg of phenoxybenzamine, i.e. a 10-fold increase in the dose of phenoxybenzamine, there was no decrease in systemic blood pressure with this dose. All these drugs in a concentration of 2 x 10(-6) M inhibited the Ca-contracture (phasic and tonic) of the depolarized aortic strips. The order of inhibition of phasic and tonic contracture was: nitroglycerin greater than E-643, verapamil greater than phentolamine greater than phenoxybenzamine. The pA2 values for phentolamine and E-643 in antagonizing contractions produced by noradrenaline of cat aortic strips were 7.8 and 8.2, respectively. Hypotensive effects of these drugs (except phenoxybenzamine), parallel the inhibitory effects on the Ca-contracture of the aortic strips. These results suggest that alpha blockers such as phentolamine and E-643 exert a systemic hypotensive effect not through their alpha blocking action but by an inhibitory action on the contractile Ca-mechanism.
为了进一步阐明肾上腺素能α受体阻滞剂的降压机制,研究了几种α受体阻滞剂对全身血压以及对离体猫主动脉条钙收缩的影响。为此,将已知的肾上腺素能α受体阻滞剂酚妥拉明、酚苄明以及一种新合成的肾上腺素能α受体阻滞剂(2-(N-(正丁酰基)高哌嗪-N'-基)-4-氨基-6,7-二甲氧基喹唑啉;E-643)的作用与硝酸甘油和维拉帕米的作用进行了比较。除酚苄明外,所有药物静脉注射(2×10⁻⁸摩尔/千克)均使全身血压降低。注射后舒张压最大降幅的顺序为:硝酸甘油>E-643>酚妥拉明>维拉帕米>酚苄明。尽管在给予2×10⁻⁷摩尔/千克酚苄明后出现了“肾上腺素翻转”,即酚苄明剂量增加了10倍,但该剂量下全身血压并未降低。所有这些药物在2×10⁻⁶摩尔/升的浓度下均抑制去极化主动脉条的钙收缩(相性和张力性)。相性和张力性收缩抑制的顺序为:硝酸甘油>E-643、维拉帕米>酚妥拉明>酚苄明。酚妥拉明和E-643拮抗猫主动脉条去甲肾上腺素引起的收缩的pA2值分别为7.8和8.2。这些药物(除酚苄明外)的降压作用与对主动脉条钙收缩的抑制作用平行。这些结果表明,酚妥拉明和E-643等α受体阻滞剂产生全身降压作用并非通过其α受体阻断作用,而是通过对收缩性钙机制的抑制作用。